Graham Capital Management »

Arcutis Biotherapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $202k 62k 3.23

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Rubric Capital Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Jpmorgan Chase & Co
Two Sigma Investments
Susquehanna International
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Arcutis Biotherapeutics